Hyperparathyroidism, secondary Clinical Trials

Delta Trials catalogs 28 clinical trials for Hyperparathyroidism, secondary in its publicly accessible dataset. Within this set, 0 currently recruiting participants and 22 trials have reached completion. This research occurs across 358 participating sites around the world. An additional 6 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 3 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.